UniQure says FDA wants another study of Huntington’s gene therapy

Agency staff "strongly recommended" a sham surgery-controlled trial be conducted before an approval filing, a stance one analyst called a "worst case scenario" for UniQure.

NCDC alarms over rising Lassa fever in 18 states – EnviroNews

March 3, 2026

Zenas looks to China to stock pipeline with 3 more immune drugs

Roche pill succeeds in another MS study, but approval questions linger

March 3, 2026

Source link

UniQure says FDA wants another study of Huntington’s gene therapy

NCDC alarms over rising Lassa fever in 18 states – EnviroNews

Roche pill succeeds in another MS study, but approval questions linger

How to Monitor Your Blood Pressure at Home (2026)

Here’s What It Needs Rally

Here's What It Needs Rally

Leave a Reply Cancel reply

RECOMMENDED NEWS

Everyone Speaks Incel Now | WIRED

Hedera HBAR Volume Surges Past $650M: Can it Reach $10

Global Athletes Unite at 2024 British Speedgolf Championships, Defying Limits and Inspiring Passion

Top scientist wants to prevent AI from going rogue

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

Mahama attends Liberia’s 178th independence anniversary

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

UniQure says FDA wants another study of Huntington’s gene therapy

Related posts

How to Monitor Your Blood Pressure at Home (2026)

Here’s What It Needs Rally

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS